Patents by Inventor Charles J. DECEDUE

Charles J. DECEDUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11918691
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, arid intracystic injection.
    Type: Grant
    Filed: January 13, 2023
    Date of Patent: March 5, 2024
    Assignee: CRITITECH, INC.
    Inventors: Gere S. Dizerega, Michael Baltezor, Sam Campbell, Charles J. Decedue, Matthew McClorey, Holly Maulhardt
  • Publication number: 20230372234
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Application
    Filed: July 13, 2023
    Publication date: November 23, 2023
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Patent number: 11737972
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Grant
    Filed: October 12, 2022
    Date of Patent: August 29, 2023
    Assignee: CRITITECH, INC.
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Publication number: 20230263731
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, arid intracystic injection.
    Type: Application
    Filed: January 13, 2023
    Publication date: August 24, 2023
    Inventors: Gere S. DIZEREGA, Michael BALTEZOR, Sam CAMPBELL, Charles J. DECEDUE, Matthew MCCLOREY
  • Publication number: 20230111288
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 13, 2023
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Patent number: 11583499
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: February 21, 2023
    Assignee: CritiTech, Inc.
    Inventors: Gere S. Dizerega, Michael Baltezor, Sam Campbell, Charles J. Decedue, Matthew McClorey
  • Patent number: 11523983
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Grant
    Filed: May 10, 2021
    Date of Patent: December 13, 2022
    Assignee: CritiTech, Inc.
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Publication number: 20220047513
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
    Type: Application
    Filed: May 28, 2021
    Publication date: February 17, 2022
    Inventors: Gere S. DIZEREGA, Michael BALTEZOR, Sam CAMPBELL, Charles J. DECEDUE, Matthew MCCLOREY
  • Publication number: 20210259959
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Application
    Filed: May 10, 2021
    Publication date: August 26, 2021
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Publication number: 20210214683
    Abstract: Disclosed are methods for the isolation of tumor-specific immune cells from subjects that have a malignant tumor and have received local administration of a composition comprising taxane particles to the malignant tumor, and use of such isolated immune cells in compositions for adoptive cell therapy and cancer vaccines.
    Type: Application
    Filed: April 12, 2019
    Publication date: July 15, 2021
    Inventors: Gere S. DIZEREGA, Holly MAULHARDT, Michael BALTEZOR, Sam CAMPBELL, Charles J. DECEDUE, William JOHNSTON, Matthew MCCLOREY, James VERCO
  • Patent number: 11058639
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: July 13, 2021
    Assignee: CritiTech, Inc.
    Inventors: Gere S. Dizerega, Michael Baltezor, Sam Campbell, Charles J. Decedue, Matthew McClorey
  • Publication number: 20200261367
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
    Type: Application
    Filed: March 30, 2020
    Publication date: August 20, 2020
    Inventors: Gere S. DIZEREGA, Michael BALTEZOR, Sam CAMPBELL, Charles J. DECEDUE, Matthew MCCLOREY
  • Publication number: 20190365698
    Abstract: Disclosed are methods useful for the therapeutic treatment of cancerous solid tumors by the administration of an antineoplastic agent, wherein the antineoplastic agent resides at the tumor site exposing the tumor to the antineoplastic agent for a sustained amount of time sufficient to stimulate the endogenous immune system of the subject resulting in the production of tumoricidal cells and infiltration of the tumoricidal cells in and around the tumor site at a level sufficient to treat the tumor. The methods include local administration methods such as topical application, pulmonary administration, intratumoral injection, and intraperitoneal injection.
    Type: Application
    Filed: January 4, 2019
    Publication date: December 5, 2019
    Inventors: Michael BALTEZOR, Sam CAMPBELL, Charles J. DECEDUE, Gere S. DIZEREGA, William JOHNSTON, Matthew MCCLOREY, James VERCO
  • Publication number: 20190365699
    Abstract: Disclosed herein are compositions and methods for treating kidney tumors by intratumoral injection administration of compositions comprising taxane particles such as docetaxel particles or paclitaxel particles.
    Type: Application
    Filed: January 4, 2019
    Publication date: December 5, 2019
    Inventors: Michael BALTEZOR, Gere DIZEREGA, Charles J. DECEDUE, Sam CAMPBELL, Matthew MCCLOREY, Holly MAULHARDT
  • Publication number: 20190365700
    Abstract: Disclosed are methods for the isolation of tumor-specific immune cells from subjects that have a malignant tumor and have received local administration of a composition comprising taxane particles to the malignant tumor, and use of such isolated immune cells in compositions for adoptive cell therapy and cancer vaccines.
    Type: Application
    Filed: April 12, 2019
    Publication date: December 5, 2019
    Inventors: Gere S. Dizerega, Holly Maulhardt, Michael Baltezor, Sam Campbell, Charles J. Decedue, William Johnston, Matthew McClorey, James Verco
  • Publication number: 20190254957
    Abstract: Disclosed herein are methods for treating epithelial cysts including pancreatic cysts in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Application
    Filed: April 12, 2019
    Publication date: August 22, 2019
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Publication number: 20190209515
    Abstract: Disclosed herein are methods for treating and inhibiting the recurrence of bladder cancer by local administration of compositions comprising taxane particles such as docetaxel particles. Administration methods include intratumoral injection, direct injection into surgical tumor resection sites, and intravesical instillation.
    Type: Application
    Filed: January 4, 2019
    Publication date: July 11, 2019
    Inventors: Gere S. DIZEREGA, Michael BALTEZOR, Charles J. DECEDUE, Sam CAMPBELL, Matthew MCCLOREY
  • Publication number: 20190209514
    Abstract: Disclosed herein are methods for treating and inhibiting the recurrence of bladder cancer by local administration of compositions comprising taxane particles such as docetaxel particles. Administration methods include intratumoral injection, direct injection into surgical tumor resection sites, and intravesical instillation.
    Type: Application
    Filed: January 4, 2019
    Publication date: July 11, 2019
    Inventors: Gere S. DIZEREGA, Michael BALTEZOR, Charles J. DECEDUE, Sam CAMPBELL, Matthew MCCLOREY
  • Publication number: 20180221849
    Abstract: An equipment assembly for preparing, harvesting and collecting particles is disclosed. The assembly comprises a tandem filter system with one or more high pressure filters, one or more low pressure filters and one or more collection vessel. Particles can be prepared, harvested and collected continuously, semi-continuously or in a batch-type operation. A tandem filter system and its method of use are also disclosed. Particles made with the assembly and according the instant methods are also disclosed. The assembly provides improved particle harvesting and collection over other systems and permits continuous particle formation, in particular by dispersion of a solute-containing process fluid within a supercritical anti-solvent.
    Type: Application
    Filed: February 12, 2018
    Publication date: August 9, 2018
    Applicant: CRITITECH, INC.
    Inventors: Greg S. JOHNSON, Bala SUBRAMANIAM, Fenghui NIU, Jahna C. ESPINOSA, Charles J. DECEDUE, Gary E. CLAPP, Jacob M. SITTENAUER
  • Patent number: 9925512
    Abstract: An equipment assembly for preparing, harvesting and collecting particles is disclosed. The assembly comprises a tandem filter system with one or more high pressure filters, one or more low pressure filters and one or more collection vessel. Particles can be prepared, harvested and collected continuously, semi-continuously or in a batch-type operation. A tandem filter system and its method of use are also disclosed. Particles made with the assembly and according the instant methods are also disclosed. The assembly provides improved particle harvesting and collection over other systems and permits continuous particle formation, in particular by dispersion of a solute-containing process fluid within a supercritical anti-solvent.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: March 27, 2018
    Assignee: CritiTech, Inc.
    Inventors: Greg S. Johnson, Bala Subramaniam, Fenghui Niu, Jahna C. Espinosa, Charles J. Decedue, Gary E. Clapp, Jacob M. Sittenauer